FLAIR-Only Progression in Bevacizumab-Treated Relapsing Glioblastoma Does Not Predict Short Survival - Concepedia

Concepedia

Publication | Closed Access

FLAIR-Only Progression in Bevacizumab-Treated Relapsing Glioblastoma Does Not Predict Short Survival

19

Citations

12

References

2013

Year

Christina Schaub, Susanne Greschus, M. Seifert, Andreas Waha, Elias Blasius, Katja Rasch, Christiane Landwehr, Frederic Mack, Niklas Schäfer, Moritz Stuplich,

Abstract

FLAIR-only progression is not an independent prognostic factor negatively influencing OS in recurrent glioblastoma treated with bevacizumab and should not lead to discontinuation of bevacizumab therapy.

References

	Year	Citations

Page 1